TRIM16 and sarcopenia: To explore whether TRIM16 overexpression could protect against age‐related sarcopenia, we administered intramuscular injections of AAV encoding TRIM16 to mice from the 18‐month‐D‐gal and 24‐month‐old groups (Figure 7A).